Announced
Financials
Sources
Tags
Acquisition
Private
Pending
Friendly
Pharmaceuticals
Majority
Single Bidder
Ireland
pharmaceutical company
Cross Border
Synopsis
ESTEVE, an international specialty pharmaceutical company, agreed to acquire the HRA Pharma Rare Diseases business of Perrigo, a pharmaceutical and consumer goods company, for €275m. "This transaction aims to advance on the path of covering the unmet patients' needs, in line with ESTEVE's purpose of improving people's lives, and is another step towards the company's vision of being an international and specialist pharma company," Staffan Schüberg, ESTEVE CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.